Aclaris Therapeutics, Inc. (ACRS)

NASDAQ: ACRS · Real-Time Price · USD

1.460

0.00 (0.00%)

At close: May 30, 2025, 4:00 PM

1.490

+0.030 (2.05%)

After-hours: May 30, 2025, 7:19 PM EDT

Aclaris Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May '25 May 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	158	265	74	1,050	890	278
Market Cap Growth	87.74%	256.84%	-92.92%	17.97%	220.59%	254.99%
Enterprise Value	-30	95	-110	805	650	238
Last Close Price	1.46	2.48	1.05	15.75	14.54	6.47
PS Ratio	7.40	14.18	2.38	35.30	131.67	42.84
PB Ratio	1.10	1.71	0.47	5.32	4.51	7.38
P/TBV Ratio	1.10	1.71	0.47	5.51	4.68	9.10
EV/Sales Ratio	-	5.06	-	27.04	96.09	36.79
Debt / Equity Ratio	0.02	0.02	0.02	0.01	0.02	0.38
Asset Turnover	0.10	0.09	0.14	0.12	0.04	0.08
Quick Ratio	4.91	3.88	3.86	9.94	8.38	3.69
Current Ratio	5.06	3.99	4.16	10.56	8.94	3.87
Return on Equity (ROE)	-91.03%	-84.46%	-49.88%	-44.01%	-77.33%	-95.12%
Return on Assets (ROA)	-18.20%	-15.72%	-31.67%	-21.04%	-25.38%	-35.87%
Return on Capital (ROIC)	-23.19%	-20.59%	-39.70%	-26.60%	-32.43%	-48.16%
Earnings Yield	-82.36%	-49.76%	-118.96%	-8.28%	-10.21%	-18.37%
FCF Yield	-7.81%	-7.61%	-107.07%	-6.49%	-5.89%	-14.08%
Buyback Yield / Dilution	-27.19%	-10.73%	-7.05%	-14.95%	-33.36%	-2.94%

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q